Guideline on the design and conduct of cystic fibrosis clinical trials: The European Cystic Fibrosis Society–Clinical Trials Network (ECFS-CTN)

Autor: De Boeck, K., Bulteel, V., Tiddens, H., Wagner, T., Fajac, I., Conway, S., Dufour, F., Smyth, A.R., Lee, T., Sermet, I., Kassai, B., Elborn, S.

Publikováno v: In Journal of Cystic Fibrosis 2011 10 Supplement 2:S67-S74

"Il faut continuer à poser des questions" patient reported outcome measures in cystic fibrosis: An anthropological perspective.

Autor: Coucke R; Service de Pneumologie et Allergologie Pédiatriques, Centre de Ressourcés et de Compétence de la Mucoviscidose, Hôpital Necker Enfants Malades 149 rue de Sévres, INSERM U1151, Institut Necker Enfants Malades, Université Paris Sorbonne, Paris 75743, France., Chansard A; CF Europe, Joseph Borlélaan 12, 1160 Brussels, Belgium., Bontemps V; Institut de Recherche Interdisciplinaire sur les Enjeux Sociaux, Campus Condorcet, Bâtiment Recherche Sud, 5 cours de Humanitiés, 93322 Aubervillers cedex, France., Grenet D; Hôpital Foch, 40 rue Worth, 92150 Suresnes, France., Hubert D; Hôpital Cochin, Assistance Publique Hôpitaux de Paris and Université de Paris, Institut Cochin, Inserm U1016, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France., Martin C; Hôpital Cochin, Assistance Publique Hôpitaux de Paris and Université de Paris, Institut Cochin, Inserm U1016, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France., Lammertyn E; CF Europe, Joseph Borlélaan 12, 1160 Brussels, Belgium., Bardin E; CF Europe, Joseph Borlélaan 12, 1160 Brussels, Belgium., Bulteel V; European Cystic Fibrosis Society, Karup, Denmark., Chedevergne F; Service de Pneumologie et Allergologie Pédiatriques, Centre de Ressourcés et de Compétence de la Mucoviscidose, Hôpital Necker Enfants Malades 149 rue de Sévres, INSERM U1151, Institut Necker Enfants Malades, Université Paris Sorbonne, Paris 75743, France., Bourgeois ML; Service de Pneumologie et Allergologie Pédiatriques, Centre de Ressourcés et de Compétence de la Mucoviscidose, Hôpital Necker Enfants Malades 149 rue de Sévres, INSERM U1151, Institut Necker Enfants Malades, Université Paris Sorbonne, Paris 75743, France., Burgel PR; Hôpital Cochin, Assistance Publique Hôpitaux de Paris and Université de Paris, Institut Cochin, Inserm U1016, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France., Honore I; Hôpital Cochin, Assistance Publique Hôpitaux de Paris and Université de Paris, Institut Cochin, Inserm U1016, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France., de Keyser H; CF Europe, Joseph Borlélaan 12, 1160 Brussels, Belgium., Kirszenbaum M; Service de Pneumologie et Allergologie Pédiatriques, Centre de Ressourcés et de Compétence de la Mucoviscidose, Hôpital Necker Enfants Malades 149 rue de Sévres, INSERM U1151, Institut Necker Enfants Malades, Université Paris Sorbonne, Paris 75743, France., de Carli P; Association Vaincre la Mucoviscidose, 181 rue de Tolbiac, 75013 Paris, France., Sermet-Gaudelus I; Service de Pneumologie et Allergologie Pédiatriques, Centre de Ressourcés et de Compétence de la Mucoviscidose, Hôpital Necker Enfants Malades 149 rue de Sévres, INSERM U1151, Institut Necker Enfants Malades, Université Paris Sorbonne, Paris 75743, France., Hayes K; European Cystic Fibrosis Society, Karup, Denmark; Northern Ireland Clinical Research Facility, The Wellcome-Wolfson Centre for Experimental Medicine, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, Ireland. Electronic address: k.hayes@qub.ac.uk.

Publikováno v: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2021 Nov; Vol. 20 (6), pp. e108-e113. Date of Electronic Publication: 2021 Feb 27.

Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures.

Autor: van Koningsbruggen-Rietschel S; University Hospital Cologne, Faculty of Medicine, University of Cologne, Kerpenerstr. 62, 50937, Cologne, Germany. Silke.vanKoningsbruggen@uk-koeln.de., Dunlevy F; European Cystic Fibrosis Society, Karup, Denmark., Bulteel V; European Cystic Fibrosis Society, Karup, Denmark., Hayes K; Queen's University Belfast, Belfast, UK., Verbrugge A; European Cystic Fibrosis Society, Karup, Denmark., Janssens HM; Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands., Dufeu N; University Aix-Marseille, Marseille, France., Simmonds NJ; Royal Brompton Hospital, London, UK., Dupont LJ; University Hospital Leuven, Leuven, Belgium., Downey DG; Queen's University Belfast, Belfast, UK.

Publikováno v: Trials [Trials] 2021 Aug 28; Vol. 22 (1), pp. 578. Date of Electronic Publication: 2021 Aug 28.

SARS-CoV-2 disrupts clinical research: the role of a rare disease-specific trial network.

Autor: van Koningsbruggen-Rietschel S; CF Centre Cologne, Children's Hospital, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany Silke.vanKoningsbruggen@uk-koeln.de., Dunlevy F; European Cystic Fibrosis Society, Karup, Denmark., Bulteel V; European Cystic Fibrosis Society, Karup, Denmark., Downey DG; Centre for Experimental Medicine, Queen's University Belfast, Belfast, UK., Dupont L; CF Center and Lung Transplant Unit, University Hospitals Leuven, Leuven, Belgium.

Publikováno v: The European respiratory journal [Eur Respir J] 2020 Sep 17; Vol. 56 (3). Date of Electronic Publication: 2020 Sep 17 (Print Publication: 2020).

Guideline on the design and conduct of cystic fibrosis clinical trials: The European Cystic Fibrosis Society-Clinical Trial Network (ECFS-CTN)

Autor: de Boeck, K, Bulteel, V, Tiddens, H.A.W.M., Wagner, T, Fajac, I, Conway, S, Dufour, F, Smyth, A, Lee, T, Sermet, I, Kassai-Koupai, B, Elborn, S

Publikováno v: Journal of Cystic Fibrosis, 9(suppl 3), S58-S65. Elsevier
Journal of Cystic Fibrosis, 10(suppl 2), S67-S74. Elsevier

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ca5d0378b5344a7218849971ce54817e
https://pure.eur.nl/en/publications/0d97b85d-75f6-41b6-b258-0d00a864c283